People may be three times more likely to have Covid symptoms after receiving an AZ vaccine than after receiving a Pfizer vaccine, according to a new study.
THE ASTRAZENECA vaccination has given the UK a significant advantage in the vaccine race, but new SAGE numbers may cause alarm as Freedom Day approaches. Those fully vaccinated with the AstraZeneca vaccination have a three-fold probability of experiencing Covid symptoms if infected, according to the panel of specialists advising Downing Street, compared to those who received Pfizer and Moderna vaccines.
The UK is speeding towards July 19, when all remaining coronavirus limitations will be lifted in England. What was supposed to be a time of national celebration has been met with growing trepidation. New SAGE data are only going to add to the angst. According to data given by the group of experts, those who were double-jabbed with the AstraZeneca vaccine were three times more likely than those who received the Pfizer and Moderna vaccines to develop symptoms of the virus.
The findings come from REACT-2, the UK’s largest surveillance project, which analyses blood samples from hundreds of thousands of Britons at random.
Antibodies were more variable in persons who had only received a single dosage, both in terms of age and vaccine type.
This figure falls significantly short of the two other coronavirus vaccines currently in use in the UK.
Two doses of AstraZeneca’s vaccine, according to Imperial College London scientists, are 55 percent effective in preventing symptoms from the Delta variation, which is now the dominant strain in the UK.
According to Imperial specialists, just 15 people would have developed symptoms if Pfizer or Moderna had been involved.
However, a clear consensus on the efficacy of the AstraZeneca vaccine has yet to emerge.
A new study published in the journal Nature has added to the confusion.
According to the research, the vaccine could provide lifelong protection against COVID-19.
The vaccine, in addition to producing virus-eliminating antibodies, builds “training camps” in the body for search-and-destroy T-cells that can kill even novel variations, according to the study.
It means that the body can keep creating these important cells long after the antibodies have worn off, possibly for the remainder of your life.
T-cell protection is a “key feature” of adenovirus vaccinations like the AZ and J&J jabs, according to Oxford and Swiss scientists writing in the journal Nature.
“The T-cells that arrive from these cellular training camps appear to have a very high level of.”Brinkwire Summary News”, said researcher Professor Burkhard Ludewig of Cantonal Hospital in Switzerland.